The Blueprint is intended to guide programming, resource allocation, and commitments to achieve the national objective of a contraceptive prevalence rate (CPR) of 36 percent by 2018.
PLoS ONE 9(1): e87262. doi:10.1371/journal.pone.0087262
Chapter 8, Prison and Health, published
Review Article: Journal of Nutritional Health & Food Science
Vitamin Deficiency and Tuberculosis: Need for Urgent Clinical Page 1- 6
Eur Respir J 2014; 43: 24–35 | DOI: 10.1183/09031936.00113413
Euro Surveillance 2014;19(47):pii=20970, p.31-37
Policy Brief
November 2014
Investigación original / Original research
Rev Panam Salud Publica 35(1), 2014
Glob Health Sci Pract February 1, 2014 vol. 2 no. 1 p. 103-116
Please read online the lastest updated versions http://www.cdc.gov/vhf/ebola/qa.html
J. European Academy of Dermatology and Venereology, 4 August 2014
The companion Handbook on Humanitarian Access presents the normative framework pertaining to humanitarian access in situations of armed conflict, and therefore serves as a useful reference source for humanitarian practitioners on the normative framework.
This initial version of the Field Manual –... labeled Version 1.0 – was elaborated by Conflict Dynamics International in collaboration with the FDFA and the UN Office for the Coordination of Humanitarian Affairs (OCHA).
Development of the structured approach and guidance contained in this Manuel
involved a consultation process which included bilateral meetings with humanitarian organizations, regional consultation events and consultations during several field visits, including dedicated field missions
more
Investigación original / Original research
Rev Panam Salud Publica 36(3), 2014
(actualizado en diciembre de 2014).
Version 1.0, 2014-11-21
Introduction:
This document lists TB indicators that can be derived from the recording and reporting tools defined
in Definitions and reporting framework for tuberculosis – 2013 revision (WHO/HTM/TB/2013.2).
Geneva, World Health Organization; 2013. (http://www.who.int/t...b/publications/definitions/en/).
More details on the rationale, calculation and use of these indicators are available in the following
publications:
• Understanding and using tuberculosis data (WHO/HTM/TB/2014.09). Geneva, World Health
Organization. 2014.
(http://www.who.int/tb/publications/understanding_and_using_tb_data/en/)
• Companion handbook to the WHO guidelines for the programmatic management of drugresistant
tuberculosis (WHO/HTM/TB/2014.11). Geneva, World Health Organization. 2014.
(http://www.who.int/tb/publications/pmdt_companionhandbook/en/)
• A guide to monitoring and evaluation for collaborative TB/HIV activities: 2014 revision. Geneva,
World Health Organization. 2014.
more
Progress in diagnosis: Akey in overcoming the MDR-TB crisis.
The expanse-TV project progress and impact brief.
Community Health Committee Training